Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Nasdaq Inc ha un obiettivo di prezzo di consenso pari a $96.88, stabilito in base alle ultime valutazioni degli analisti di 17. Le ultime 3 valutazioni degli analisti sono state rilasciate da Barclays, TD Cowen y Raymond James il octubre 22, 2025, octubre 22, 2025 y octubre 13, 2025. Con un obiettivo di prezzo medio di $101.67 tra le Barclays, TD Cowen y Raymond James, c'è un implicito 15.05% upside per Nasdaq Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Barclays
TD Cowen
Raymond James
Morgan Stanley
Piper Sandler
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Nasdaq
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/22/2025 | 23.35% | Barclays | $108 → $109 | Maintains | Overweight | |||
10/22/2025 | 8.63% | TD Cowen | $94 → $96 | Maintains | Hold | |||
10/13/2025 | 13.16% | Raymond James | $99 → $100 | Maintains | Outperform | |||
10/08/2025 | 22.21% | Barclays | $109 → $108 | Maintains | Overweight | |||
10/01/2025 | 1.84% | Morgan Stanley | $86 → $90 | Maintains | Equal-Weight | |||
08/04/2025 | 17.69% | Piper Sandler | $97 → $104 | Maintains | Overweight | |||
07/25/2025 | 23.35% | Barclays | $101 → $109 | Maintains | Overweight | |||
07/25/2025 | 22.21% | RBC Capital | $95 → $108 | Maintains | Outperform | |||
07/25/2025 | 17.69% | Keefe, Bruyette & Woods | $103 → $104 | Maintains | Outperform | |||
07/25/2025 | 30.13% | UBS | $95 → $115 | Upgrade | Neutral → Buy | |||
07/25/2025 | 18.82% | Deutsche Bank | $97 → $105 | Maintains | Buy | |||
07/15/2025 | 14.29% | Oppenheimer | $96 → $101 | Maintains | Outperform | |||
07/15/2025 | 9.77% | Piper Sandler | $83 → $97 | Maintains | Overweight | |||
07/15/2025 | -2.68% | Morgan Stanley | $75 → $86 | Maintains | Equal-Weight | |||
07/10/2025 | 7.5% | UBS | $82 → $95 | Maintains | Neutral | |||
07/10/2025 | 14.29% | Barclays | $84 → $101 | Maintains | Overweight | |||
07/09/2025 | 8.63% | Raymond James | $84 → $96 | Maintains | Outperform | |||
07/02/2025 | 9.77% | Goldman Sachs | $85 → $97 | Maintains | Buy | |||
06/17/2025 | 8.63% | Oppenheimer | $85 → $96 | Maintains | Outperform | |||
04/28/2025 | -15.13% | Morgan Stanley | $74 → $75 | Maintains | Equal-Weight | |||
04/25/2025 | -0.42% | Keefe, Bruyette & Woods | $87 → $88 | Maintains | Outperform | |||
04/25/2025 | -7.21% | UBS | $76 → $82 | Maintains | Neutral | |||
04/25/2025 | -4.95% | Barclays | $86 → $84 | Maintains | Overweight | |||
04/14/2025 | -2.68% | Barclays | $87 → $86 | Maintains | Overweight | |||
04/11/2025 | -3.81% | Oppenheimer | $89 → $85 | Maintains | Outperform | |||
04/10/2025 | 7.5% | RBC Capital | $95 → $95 | Reiterates | Outperform → Outperform | |||
04/08/2025 | -16.26% | Morgan Stanley | $96 → $74 | Downgrade | Overweight → Equal-Weight | |||
04/08/2025 | -15.13% | Citigroup | $84 → $75 | Maintains | Neutral | |||
04/08/2025 | -6.08% | Piper Sandler | $80 → $83 | Maintains | Overweight | |||
04/07/2025 | -1.55% | Barclays | $95 → $87 | Maintains | Overweight | |||
04/02/2025 | 18.82% | B of A Securities | $103 → $105 | Maintains | Buy | |||
01/30/2025 | 0.71% | UBS | $79 → $89 | Maintains | Neutral | |||
01/30/2025 | 7.5% | RBC Capital | $95 → $95 | Reiterates | Outperform → Outperform | |||
01/30/2025 | 7.5% | JP Morgan | $88 → $95 | Maintains | Overweight | |||
01/30/2025 | 7.5% | Barclays | $96 → $95 | Maintains | Overweight | |||
01/13/2025 | 0.71% | Oppenheimer | $86 → $89 | Maintains | Outperform | |||
01/13/2025 | 8.63% | Barclays | $97 → $96 | Maintains | Overweight | |||
01/10/2025 | -4.95% | Citigroup | $78 → $84 | Maintains | Neutral | |||
01/09/2025 | -4.95% | Raymond James | $83 → $84 | Maintains | Outperform | |||
01/09/2025 | 7.5% | RBC Capital | $95 → $95 | Reiterates | Outperform → Outperform | |||
01/08/2025 | 10.9% | Deutsche Bank | $80 → $98 | Upgrade | Hold → Buy | |||
12/20/2024 | 2.98% | Keefe, Bruyette & Woods | $86 → $91 | Maintains | Outperform | |||
12/09/2024 | 9.77% | Barclays | $87 → $97 | Maintains | Overweight | |||
11/25/2024 | — | William Blair | — | Initiates | → Outperform | |||
11/19/2024 | -0.42% | RBC Capital | $88 → $88 | Reiterates | Outperform → Outperform | |||
11/11/2024 | -9.47% | Deutsche Bank | $78 → $80 | Maintains | Hold | |||
11/05/2024 | -7.21% | Argus Research | $76 → $82 | Maintains | Buy | |||
10/28/2024 | -9.47% | TD Cowen | $81 → $80 | Maintains | Hold | |||
10/25/2024 | -1.55% | Barclays | $84 → $87 | Maintains | Overweight | |||
10/25/2024 | -0.42% | RBC Capital | $88 → $88 | Reiterates | Outperform → Outperform | |||
10/25/2024 | -2.68% | Oppenheimer | $84 → $86 | Maintains | Outperform | |||
10/25/2024 | 5.24% | Morgan Stanley | $92 → $93 | Maintains | Overweight | |||
10/17/2024 | 4.11% | Morgan Stanley | $85 → $92 | Maintains | Overweight | |||
10/14/2024 | -7.21% | Raymond James | → $82 | Upgrade | Market Perform → Outperform | |||
10/14/2024 | -4.95% | Oppenheimer | $80 → $84 | Maintains | Outperform | |||
10/08/2024 | -10.6% | UBS | $73 → $79 | Maintains | Neutral | |||
10/08/2024 | -0.42% | RBC Capital | $88 → $88 | Reiterates | Outperform → Outperform | |||
10/08/2024 | -9.47% | Piper Sandler | $73 → $80 | Maintains | Overweight | |||
10/07/2024 | -4.95% | Barclays | $77 → $84 | Maintains | Overweight | |||
10/03/2024 | -0.42% | B of A Securities | $90 → $88 | Maintains | Buy | |||
10/03/2024 | -6.08% | Goldman Sachs | $77 → $83 | Maintains | Buy | |||
09/27/2024 | -0.42% | RBC Capital | → $88 | Initiates | → Outperform | |||
09/26/2024 | -6.08% | TD Cowen | → $83 | Initiates | → Hold | |||
09/09/2024 | -9.47% | Oppenheimer | $78 → $80 | Maintains | Outperform | |||
09/04/2024 | 1.84% | B of A Securities | $53 → $90 | Upgrade | Underperform → Buy | |||
08/15/2024 | -18.52% | Deutsche Bank | $66 → $72 | Maintains | Hold | |||
07/30/2024 | -11.73% | Oppenheimer | $75 → $78 | Maintains | Outperform | |||
07/26/2024 | -15.13% | Oppenheimer | $72 → $75 | Maintains | Outperform | |||
07/26/2024 | -12.87% | Barclays | $74 → $77 | Maintains | Overweight | |||
07/26/2024 | -11.73% | Keefe, Bruyette & Woods | $76 → $78 | Maintains | Outperform | |||
07/10/2024 | -16.26% | Barclays | $73 → $74 | Maintains | Overweight | |||
05/14/2024 | -25.31% | Argus Research | $64 → $66 | Maintains | Buy | |||
05/08/2024 | -27.58% | Rosenblatt | $76 → $64 | Downgrade | Buy → Neutral | |||
04/26/2024 | -17.39% | Barclays | $76 → $73 | Maintains | Overweight | |||
04/26/2024 | -16.26% | Keefe, Bruyette & Woods | $75 → $74 | Maintains | Outperform | |||
04/26/2024 | -14% | Rosenblatt | $82 → $76 | Maintains | Buy | |||
04/11/2024 | -14% | Barclays | → $76 | Initiates | → Overweight | |||
04/09/2024 | -9.47% | Morgan Stanley | $59 → $80 | Upgrade | Equal-Weight → Overweight | |||
03/26/2024 | -17.39% | Goldman Sachs | → $73 | Upgrade | Neutral → Buy | |||
02/01/2024 | -19.66% | Piper Sandler | $70 → $71 | Maintains | Overweight | |||
02/01/2024 | -23.05% | Oppenheimer | $65 → $68 | Maintains | Outperform | |||
02/01/2024 | -7.21% | Rosenblatt | → $82 | Reiterates | Buy → Buy | |||
01/24/2024 | -32.1% | UBS | $56 → $60 | Maintains | Neutral | |||
01/12/2024 | -28.71% | Citigroup | $56 → $63 | Maintains | Neutral | |||
12/01/2023 | -34.37% | Goldman Sachs | → $58 | Reinstates | → Neutral | |||
10/19/2023 | -28.71% | JP Morgan | $62 → $63 | Maintains | Overweight | |||
10/19/2023 | -37.76% | Morgan Stanley | $54 → $55 | Maintains | Equal-Weight | |||
10/19/2023 | -26.45% | Oppenheimer | → $65 | Reiterates | Outperform → Outperform | |||
10/19/2023 | -7.21% | Rosenblatt | → $82 | Reiterates | Buy → Buy | |||
10/12/2023 | -7.21% | Rosenblatt | → $82 | Reiterates | Buy → Buy | |||
10/11/2023 | -38.89% | Morgan Stanley | $55 → $54 | Maintains | Equal-Weight | |||
07/25/2023 | -37.76% | Morgan Stanley | $55 → $55 | Reiterates | Equal-Weight → Equal-Weight | |||
07/20/2023 | -7.21% | Rosenblatt | → $82 | Reiterates | Buy → Buy | |||
07/13/2023 | -37.76% | Morgan Stanley | $60 → $55 | Maintains | Equal-Weight | |||
07/11/2023 | -7.21% | Rosenblatt | → $82 | Reiterates | Buy → Buy | |||
06/13/2023 | -40.02% | Deutsche Bank | $56 → $53 | Maintains | Hold | |||
06/13/2023 | -36.63% | UBS | $62 → $56 | Maintains | Neutral | |||
06/13/2023 | -7.21% | Rosenblatt | → $82 | Reiterates | Buy → Buy | |||
04/20/2023 | -7.21% | Rosenblatt | → $82 | Reiterates | → Buy | |||
04/20/2023 | -26.45% | Oppenheimer | $64 → $65 | Maintains | Outperform |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Nasdaq (NDAQ)?
El último precio objetivo de Nasdaq (NASDAQ:NDAQ) fue comunicado por Barclays el octubre 22, 2025. La firma de analistas fijó un precio objetivo para $109.00 que espera NDAQ a rise dentro de 12 meses (un posible 23.35% upside). 52 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Nasdaq (NDAQ)?
La última calificación de analistas para Nasdaq (NASDAQ:NDAQ) fue proporcionada por Barclays, y Nasdaq mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de Nasdaq (NDAQ)?
La última revisión al alza de Nasdaq Inc se produjo en julio 25, 2025, cuando UBS elevó su precio objetivo a $115. UBS anteriormente tenía a neutral para Nasdaq Inc.
¿Cuándo fue la última revisión a la baja de Nasdaq (NDAQ)?
La última revisión a la baja de Nasdaq Inc se produjo en abril 8, 2025, cuando Morgan Stanley cambió su precio objetivo de $96 a $74 para Nasdaq Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Nasdaq (NDAQ)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Nasdaq, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Nasdaq se registró el octubre 22, 2025, por lo que la próxima calificación estará disponible en torno al octubre 22, 2026.
¿Es correcta la calificación de los analistas sobre Nasdaq (NDAQ)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Nasdaq (NDAQ) fue un mantuvo con un precio objetivo de $108.00 a $109.00. El precio actual al que cotiza Nasdaq (NDAQ) es de $88.37, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.